UTHealth Houston set to enroll patients for long COVID clinical trials
Two clinical trials that will evaluate drugs, biologics, medical devices, and other therapies for long COVID that are sponsored by the National Institutes of Health (NIH) will launch at UTHealth Houston.
The trials are part of the NIH Researching COVID to Enhance Recovery Initiative (RECOVER), a large, nationwide research program designed to understand, treat, and prevent long COVID, which is marked by long-term symptoms following infection by SARS-CoV-2, the virus that causes COVID-19.
The UTHealth Houston site will be led by Luis Ostrosky, MD, professor of medicine and epidemiology, division director of infection diseases, and Memorial Hermann Chair at McGovern Medical School.